`
`FORM 9. Certificate of Interest
`
`UNITED STATES COURT OF APPEALS
`FOR THE FEDERAL CIRCUIT
`
`CERTIFICATE OF INTEREST
`
`
`Case Number
`Short Case Caption
`Filing Party/Entity
`
`
`22-1595
`
`Genentech, Inc. v. Sandoz, Inc.
`
`Sandoz, Inc. and Lek Pharmaceuticals D.D.
`
`Form 9 (p. 1)
`July 2020
`
`
`
`
`
`
`
`
`Instructions: Complete each section of the form. In answering items 2 and 3, be
`specific as to which represented entities the answers apply; lack of specificity may
`result in non-compliance. Please enter only one item per box; attach
`additional pages as needed and check the relevant box. Counsel must
`immediately file an amended Certificate of Interest if information changes. Fed.
`Cir. R. 47.4(b).
`
`I certify the following information and any attached sheets are accurate and
`complete to the best of my knowledge.
`
`
`04/07/2022
`Date: _________________
`
`
`
`
`
`
`
`
`Signature:
`
`/s/ William M. Jay
`
`
`
`
`Name:
`
`William M. Jay
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case: 22-1595 Document: 5 Page: 2 Filed: 04/07/2022
`
`FORM 9. Certificate of Interest
`
`1. Represented
`Entities.
`Fed. Cir. R. 47.4(a)(1).
`Provide the full names of
`all entities represented
`by undersigned counsel in
`this case.
`
`Form 9 (p. 2)
`July 2020
`
`2. Real Party in
`Interest.
`Fed. Cir. R. 47.4(a)(2).
`Provide the full names of
`all real parties in interest
`for the entities. Do not
`list the real parties if
`they are the same as the
`entities.
`
`3. Parent Corporations
`and Stockholders.
`Fed. Cir. R. 47.4(a)(3).
`Provide the full names of
`all parent corporations
`for the entities and all
`publicly held companies
`that own 10% or more
`stock in the entities.
`
`(cid:1798) None/Not Applicable (cid:1798) None/Not Applicable
`
`✔
`
`Sandoz, Inc.
`
`Lek Pharmaceutics D.D.
`
`Novartis AG
`
`Novartis Pharma AG
`
`Novartis AG
`
`Additional pages attached
`
`
`
`Case: 22-1595 Document: 5 Page: 3 Filed: 04/07/2022
`
`FORM 9. Certificate of Interest
`
`Form 9 (p. 3)
`July 2020
`
`4. Legal Representatives. List all law firms, partners, and associates that (a)
`appeared for the entities in the originating court or agency or (b) are expected to
`appear in this court for the entities. Do not include those who have already
`entered an appearance in this court. Fed. Cir. R. 47.4(a)(4).
`None/Not Applicable
`Additional pages attached
`
`✔
`
`5. Related Cases. Provide the case titles and numbers of any case known to be
`pending in this court or any other court or agency that will directly affect or be
`directly affected by this court’s decision in the pending appeal. Do not include the
`originating case number(s) for this case. Fed. Cir. R. 47.4(a)(5). See also Fed. Cir.
`R. 47.5(b).
`None/Not Applicable
`
`Additional pages attached
`
`✔
`
`6. Organizational Victims and Bankruptcy Cases. Provide any information
`required under Fed. R. App. P. 26.1(b) (organizational victims in criminal cases)
`and 26.1(c) (bankruptcy case debtors and trustees). Fed. Cir. R. 47.4(a)(6).
`None/Not Applicable
`Additional pages attached
`
`✔
`
`
`
`Case: 22-1595 Document: 5 Page: 4 Filed: 04/07/2022
`
`UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
`
`CERTIFICATE OF INTEREST
`
`Genentech, Inc. v. Sandoz(cid:15) Inc. (Case No. 22-1595)
`
`(cid:23)(cid:17) Legal Representatives (continued from page 3):
`
`(cid:120) Goodwin Procter LLP
`o Beth Ashbridge
`o Cindy Chang*
`o Elaine H. Blais
`o Kathleen A. McGuinness
`o Kevin J. DeJong
`o Nicholas K. Mitrokostas*
`o Srikanth K. Reddy
`o Tara R. Melillo Thigpen
`o Tiffany Mahmood
`(cid:120) Bay(cid:68)rd, P.A.
`o Ronald P. Golden, III
`o Sarah Theresa Andrade
`o Stephen B. Brauerman
`
`*Denotes that attorney is no longer(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)Goodwin Procter LLP(cid:17)
`
`